GCC Prostaglandin E2 Receptor EP4 Subtype Market Research Report 2018

Publisher Name :
Date: 12-Apr-2018
No. of pages: 102
Inquire Before Buying

The global Prostaglandin E2 Receptor EP4 Subtype market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

GCC plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Prostaglandin E2 Receptor EP4 Subtype development status and future trend in GCC, focuses on top players in GCC, also splits Prostaglandin E2 Receptor EP4 Subtype by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in GCC market include

- Eisai Co Ltd

- Eli Lilly and Co

- Kaken Pharmaceutical Co Ltd

- Ono Pharmaceutical Co Ltd

- RaQualia Pharma Inc

- Rottapharm Biotech Srl

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- E-7046

- ER-886046

- grapiprant

- KAG-308

- ONO-4232

- Others

On the basis of the end users/Application, this report covers

- Breast Cancer

- Allergies

- Chronic Pain

- Acute Pain

- Lung Cancer

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

GCC Prostaglandin E2 Receptor EP4 Subtype Market Research Report 2018

Table of Contents
GCC Prostaglandin E2 Receptor EP4 Subtype Market Research Report 2018
1 Prostaglandin E2 Receptor EP4 Subtype Overview
1.1 Product Overview and Scope of Prostaglandin E2 Receptor EP4 Subtype
1.2 Classification of Prostaglandin E2 Receptor EP4 Subtype by Product Category
1.2.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Market Share by Type in 2017
1.2.3 E-7046
1.2.4 ER-886046
1.2.5 grapiprant
1.2.6 KAG-308
1.2.7 ONO-4232
1.2.8 Others
1.3 GCC Prostaglandin E2 Receptor EP4 Subtype Market by Application/End Users
1.3.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Breast Cancer
1.3.3 Allergies
1.3.4 Chronic Pain
1.3.5 Acute Pain
1.3.6 Lung Cancer
1.3.7 Others
1.4 GCC Revenue and Sales of Prostaglandin E2 Receptor EP4 Subtype (2013-2025)
1.4.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 GCC Prostaglandin E2 Receptor EP4 Subtype Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 GCC Prostaglandin E2 Receptor EP4 Subtype Market Competition by Players/Manufacturers
2.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 GCC Prostaglandin E2 Receptor EP4 Subtype Revenue and Share by Players/Manufacturers (2013-2018)
2.3 GCC Prostaglandin E2 Receptor EP4 Subtype Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 GCC Prostaglandin E2 Receptor EP4 Subtype Market Competitive Situation and Trends
2.4.1 GCC Prostaglandin E2 Receptor EP4 Subtype Market Concentration Rate
2.4.2 GCC Prostaglandin E2 Receptor EP4 Subtype Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in GCC Market
2.5 GCC Players/Manufacturers Prostaglandin E2 Receptor EP4 Subtype Manufacturing Base Distribution, Sales Area, Product Type
3 GCC Prostaglandin E2 Receptor EP4 Subtype Sales and Revenue (Value) by Type (2013-2018)
3.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 GCC Prostaglandin E2 Receptor EP4 Subtype Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 GCC Prostaglandin E2 Receptor EP4 Subtype Price (USD/Pcs) by Type (2013-2018)
3.4 GCC Prostaglandin E2 Receptor EP4 Subtype Sales Growth Rate (%) by Type (2013-2018)
4 GCC Prostaglandin E2 Receptor EP4 Subtype Sales by Application (2013-2018)
4.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 GCC Prostaglandin E2 Receptor EP4 Subtype Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 GCC Prostaglandin E2 Receptor EP4 Subtype Players/Suppliers Profiles and Sales Data
5.1 Eisai Co Ltd
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Eli Lilly and Co
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Kaken Pharmaceutical Co Ltd
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Ono Pharmaceutical Co Ltd
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 RaQualia Pharma Inc
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Rottapharm Biotech Srl
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Prostaglandin E2 Receptor EP4 Subtype Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
6 Prostaglandin E2 Receptor EP4 Subtype Manufacturing Cost Analysis
6.1 Prostaglandin E2 Receptor EP4 Subtype Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostaglandin E2 Receptor EP4 Subtype
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Prostaglandin E2 Receptor EP4 Subtype Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostaglandin E2 Receptor EP4 Subtype Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 GCC Prostaglandin E2 Receptor EP4 Subtype Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Forecast by Type (2018-2025)
10.3 GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure GCC Market Size (Million USD) Status and Outlook (2013-2025)
Table Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Prostaglandin E2 Receptor EP4 Subtype
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share by Type in 2017
Figure E-7046 Product Picture
Figure ER-886046 Product Picture
Figure grapiprant Product Picture
Figure KAG-308 Product Picture
Figure ONO-4232 Product Picture
Figure Others Product Picture
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Comparison by Application (2013-2025)
Figure GCC Sales Market Share (%) of Prostaglandin E2 Receptor EP4 Subtype by Application in 2017
Figure Breast Cancer Examples
Figure Allergies Examples
Figure Chronic Pain Examples
Figure Acute Pain Examples
Figure Lung Cancer Examples
Figure Others Examples
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales of Key Players/Manufacturers (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 GCC Prostaglandin E2 Receptor EP4 Subtype Sales Share (%) by Players/Manufacturers
Figure 2017 GCC Prostaglandin E2 Receptor EP4 Subtype Sales Share (%) by Players/Manufacturers
Table GCC Prostaglandin E2 Receptor EP4 Subtype Revenue by Players/Manufacturers (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 GCC Prostaglandin E2 Receptor EP4 Subtype Revenue Share (%) by Players/Manufacturers
Figure 2017 GCC Prostaglandin E2 Receptor EP4 Subtype Revenue Share (%) by Players/Manufacturers
Table GCC Market Prostaglandin E2 Receptor EP4 Subtype Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure GCC Market Prostaglandin E2 Receptor EP4 Subtype Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Market Share of Top 3 Players/Manufacturers
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Market Share of Top 5 Players/Manufacturers
Table GCC Players/Manufacturers Prostaglandin E2 Receptor EP4 Subtype Manufacturing Base Distribution and Sales Area
Table GCC Players/Manufacturers Prostaglandin E2 Receptor EP4 Subtype Product Category
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) by Type (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales Share (%) by Type (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Share (%) by Type (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) by Type in 2017
Table GCC Prostaglandin E2 Receptor EP4 Subtype Revenue (Million USD) and Market Share by Type (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Prostaglandin E2 Receptor EP4 Subtype by Type (2013-2018)
Figure Revenue Market Share of Prostaglandin E2 Receptor EP4 Subtype by Type in 2017
Table GCC Prostaglandin E2 Receptor EP4 Subtype Price (USD/Pcs) by Type (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Growth Rate (%) by Type (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) by Application (2013-2018)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) by Application (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) by Application (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) by Application in 2017
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales Growth Rate (%) by Application (2013-2018)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Growth Rate (%) by Application (2013-2018)
Table Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Basic Information List
Table Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales Market Share (%) in GCC (2013-2018)
Figure Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share (%) in GCC (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostaglandin E2 Receptor EP4 Subtype
Figure Manufacturing Process Analysis of Prostaglandin E2 Receptor EP4 Subtype
Figure Prostaglandin E2 Receptor EP4 Subtype Industrial Chain Analysis
Table Raw Materials Sources of Prostaglandin E2 Receptor EP4 Subtype Major Players/Manufacturers in 2017
Table Major Buyers of Prostaglandin E2 Receptor EP4 Subtype
Table Distributors/Traders List
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Price (USD/Pcs) Trend Forecast (2018-2025)
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Forecast by Type (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Forecast by Type (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share Forecast by Type in 2025
Table GCC Prostaglandin E2 Receptor EP4 Subtype Sales (K Pcs) Forecast by Application (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share Forecast by Application (2018-2025)
Figure GCC Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share Forecast by Application in 2025
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is ......
  • Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler's diarrhea is the leading cause of illness among international tra......
  • Global Anticoagulant Drugs Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoag......
  • Global OTC Herbal and Traditional Medicines Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 184
    Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease. Herbal medicine industry is dispersive relatively. Currently, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs